Syn-Med-Chemist-"Quintessential Synthetic Chemistry"---A Synthetic Chemist's Perception......
Monday, December 15, 2014
MorphoSys, Xencor announce final results from MOR208 Phase 1/2a trial in patients with CLL/SLL
MorphoSys, Xencor announce final results from MOR208 Phase 1/2a trial in patients with CLL/SLL
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment